LCM
PHVS icon

Lynx1 Capital Management’s Pharvaris PHVS Stock Holding History

Lynx1 Capital Management’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-21,225
Closed -$321K – 24
2023
Q2 		$321K Sell
21,225
-5,000
-19% -$48.4K 0.21% 16
2023
Q1 		$211K Buy
26,225
+900
+4% +$7.92K 0.18% 13
2022
Q4 		$285K Buy
+25,325
New +$133K 0.25% 13

Other funds holding PHVS

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Lynx1 Capital Management's PHVS Position: Q3 2023 in Review

Lynx1 Capital Management sold out of Pharvaris (PHVS) in Q3 2023, closing a stake of 21,225 shares — an estimated $321K sold.

Lynx1 Capital Management first reported a position in PHVS in Q4 2022 and held it in 3 quarters. The position peaked at $321K in Q2 2023. 21 funds tracked by Wall St. Rank hold PHVS as of Q3 2023.

  • Lynx1 Capital Management reported no remaining Pharvaris position as of Q3 2023 after selling out during the quarter.
  • Lynx1 Capital Management sold 21,225 Pharvaris shares in Q3 2023, an estimated $321K.
  • Lynx1 Capital Management first reported a position in Pharvaris in Q4 2022 and held it in 3 quarters.
  • Lynx1 Capital Management's Pharvaris position peaked at $321K in Q2 2023.
  • 21 funds tracked by Wall St. Rank held Pharvaris as of Q3 2023.

Based on Lynx1 Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.